ulcerative-colitis

Documents about ulcerative-colitis

• Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis#838151ClinicalTrials.gov
• A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)#866768ClinicalTrials.gov
• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis#886338ClinicalTrials.gov
• Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis#896750ClinicalTrials.gov
• Ulcerative Colitis Relapse Prevention Trial, Hypnosis#918123ClinicalTrials.gov
• A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease#1009947ClinicalTrials.gov
• Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)#866662ClinicalTrials.gov
• Study of the Safety and Tolerability of ALTH12 Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis#849933ClinicalTrials.gov
• Dose Escalation and Remission (DEAR)#162382ClinicalTrials.gov
• ABTECT - Maintenance#800797ClinicalTrials.gov
• Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension#665317HAL (France)
• Surveillance in Ulcerative Colitis: Narrow Band Image Versus Chromoendoscopy for High-risk Groups#804517ClinicalTrials.gov
• Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis#813960ClinicalTrials.gov
• A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis#844889ClinicalTrials.gov
• The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis#858546ClinicalTrials.gov
• A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis#862179ClinicalTrials.gov
• Study of the Pharmacokinetics of Golimumab in Moderate to Severe Ulcerative Colitis#909336ClinicalTrials.gov
• A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis#915892ClinicalTrials.gov
• Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis#918487ClinicalTrials.gov
• Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review#983870HAL (France)
• The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis#1008339ClinicalTrials.gov
• Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT)#1046573ClinicalTrials.gov
• The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis#982700ClinicalTrials.gov
• Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative Colitis#830035ClinicalTrials.gov
• Safety and Efficacy of Heterologous FMT by SQIMC-md Capsule in Mild-moderate Ulcerative Colitis Patients#842671ClinicalTrials.gov
• A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis#844629ClinicalTrials.gov
• A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)#869954ClinicalTrials.gov
• An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis#870416ClinicalTrials.gov
• CT to Assess the Efficacy and Safety of Adding GMA to Infliximab in Paediatric Patients With Steroid-refractory Ulcerative Colitis#912128ClinicalTrials.gov
• Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability Study#913898ClinicalTrials.gov
• Prebiotics in Reducing Inflammation and Clinical Endpoints in Ulcerative Colitis (PRInCE-UC)#1030995ClinicalTrials.gov
• Syndecan 1 as Biomarker for Inflammation#876530ClinicalTrials.gov
• Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis#665320HAL (France)
• The Clinical Value of Chromoendoscopy as Surveillance Strategy for Dysplasia Detection in Ulcerative Colitis#824970ClinicalTrials.gov
• Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus.#847640ClinicalTrials.gov
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)#862287ClinicalTrials.gov
• Fecal Microbiota Transplantation for Ulcerative Colitis#883894ClinicalTrials.gov
• Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC)#884397ClinicalTrials.gov
• A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis#886912ClinicalTrials.gov
• Compare Conventional Colonosocpy to Endoscopic AFI, NBI for Dysplasia Detection for Ulcerative Colitis & Cholangitis#910140ClinicalTrials.gov
• A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis#914790ClinicalTrials.gov
• Food Supplementation With VSL#3 as a Support to Standard Pharmaceutical Therapy in Ulcerative Colitis#915098ClinicalTrials.gov
• A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis#917355ClinicalTrials.gov
• The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis#980662ClinicalTrials.gov
• STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission#991974ClinicalTrials.gov
• A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean Participants#1007904ClinicalTrials.gov
• Noninterventional Observational Prospective Longitudinal Study of the Incidence of Ulcerative Colitis and Crohn's Disease Among the Adult Population of the Republic of Kazakhstan#834383ClinicalTrials.gov
• Evaluation of the Effects of Colipral on Microbiota Gut Composition in Patients Presenting With Ulcerative Colitis During Remission Phase and Functional Disorders#896212ClinicalTrials.gov
• Is Hartmann’s Pouch an Option in the Management of Acute Severe Ulcerative Colitis?#643006HAL (France)
• Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Ulcerative Colitis and Crohn Disease#805161ClinicalTrials.gov